Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

NCT: NCT04559945 · COMPLETED

NCT IDNCT04559945
StatusCOMPLETED
Start Date2020-11-13
Completion2023-09-15
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

prospective, non-randomized, multi-center, international clinical study is designed to confirm the safety and effectiveness of the Aveir LP System in a subject population indicated for a VVI(R) pacemaker.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑